| Chany Damian Ozuna Corporan, MD | |
|
725 E Adams St Fl 2, Syracuse, NY 13210-2576 | |
| (315) 464-6100 | |
| Not Available |
| Full Name | Chany Damian Ozuna Corporan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 725 E Adams St Fl 2, Syracuse, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407460348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 0101277159 (Virginia) | Secondary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 326233 (New York) | Primary |
| Entity Name | Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063468239 PECOS PAC ID: 3274445796 Enrollment ID: O20031104000051 |
News Archive
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
With the summer months upon us, Lyme disease and other tick-borne illnesses are on the rise in the United States. According to the U.S. Centers for Disease Control and Prevention, tick-borne diseases are increasing, with human cases expected to exceed 300,000 annually.
As the international community on Monday marked the ninth annual International Day of Zero Tolerance to Female Genital Mutilation/Cutting (FGM/C), the U.N. and international and human rights organizations called for an end to FGM/C and are appealing for tougher legislation to halt the practice that has affected up to 140 million girls and women worldwide, according to WHO statistics, VOA News reports.
In a study published in the journal Drugs, a researcher tackled the approval of Pfizer-BioNTech's COVID-19 vaccine, which has now been used in many countries.
Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chany Damian Ozuna Corporan, MD 725 E Adams St Fl 2, Syracuse, NY 13210-2576 Ph: () - | Chany Damian Ozuna Corporan, MD 725 E Adams St Fl 2, Syracuse, NY 13210-2576 Ph: (315) 464-6100 |
News Archive
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
With the summer months upon us, Lyme disease and other tick-borne illnesses are on the rise in the United States. According to the U.S. Centers for Disease Control and Prevention, tick-borne diseases are increasing, with human cases expected to exceed 300,000 annually.
As the international community on Monday marked the ninth annual International Day of Zero Tolerance to Female Genital Mutilation/Cutting (FGM/C), the U.N. and international and human rights organizations called for an end to FGM/C and are appealing for tougher legislation to halt the practice that has affected up to 140 million girls and women worldwide, according to WHO statistics, VOA News reports.
In a study published in the journal Drugs, a researcher tackled the approval of Pfizer-BioNTech's COVID-19 vaccine, which has now been used in many countries.
Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508.
› Verified 3 days ago
Courtney Myers, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 750 E Adams St Ste 311, Syracuse, NY 13210 Phone: 315-464-5815 | |
Joan Marie Mitchell, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-425-4828 Fax: 315-425-4827 | |
Gordana Obradovic, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1304 Buckley Rd, Suite 200, Syracuse, NY 13212 Phone: 315-478-3311 Fax: 315-476-5211 | |
Kristin A Ramella, NP Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 90 Presidential Plz Ste 5010, Syracuse, NY 13202 Phone: 315-464-9335 | |
Vinodhini M Subramanian, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-470-7111 | |
Robert R. Michiel, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 90 Presidential Plz, 5th Floor, Syracuse, NY 13202 Phone: 315-464-9335 Fax: 315-464-9338 | |
Michael P Gabris, MD FACC Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Genesee St, Suite 300, Syracuse, NY 13210 Phone: 315-471-1044 Fax: 315-474-4312 |